Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Black Diamond Therapeutics Announces Expected 2024 Milestones; Co. Exploring The Potential Development Of BDTX-1535 In First-line Patients Who Are Post-Osimertinib Adjuvant Treatment.

Author: Benzinga Newsdesk | January 04, 2024 09:09am

Posted In: BDTX